New study checks safety of weekly diabetes shot in chile
NCT ID NCT05533632
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 27 times
Summary
This study looked at how safe and tolerable a weekly injection of semaglutide (a diabetes drug) is for people with type 2 diabetes in Chile. About 104 adults took part, receiving a dose chosen by their doctor for 24 weeks. Researchers tracked side effects and measured changes in blood sugar control. The goal was to confirm the medicine's safety in this specific group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hospital Padre Hurtado
Santiago, Región Metropolitana, 8880465, Chile
-
Hospital San Juan de Dios_Santiago, Región Metropolitana
Santiago, Región Metropolitana, 8350429, Chile
-
Servicios Médicos Godoy Limitada
Santiago, Región Metropolitana, 7500710, Chile
Conditions
Explore the condition pages connected to this study.